Britannia Life Sciences, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 100.00% vs -88.89% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 3,700.00% vs -200.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.40",
          "val2": "0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-0.60",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.80",
          "val2": "-0.30",
          "chgp": "3,700.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-180.70%",
          "val2": "-3,690.60%",
          "chgp": "350.99%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -94.74% vs 18.75% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -4.55% vs -175.86% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.40",
          "val2": "7.60",
          "chgp": "-94.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.20",
          "val2": "-3.70",
          "chgp": "40.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "1.30",
          "chgp": "-92.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "1.40",
          "chgp": "-78.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.60",
          "val2": "-4.40",
          "chgp": "-4.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,999.70%",
          "val2": "-526.80%",
          "chgp": "-547.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

0.40

0.20

100.00%

Operating Profit (PBDIT) excl Other Income

-0.10

-0.60

83.33%

Interest

0.00

0.10

-100.00%

Exceptional Items

-1.40

0.00

Consolidate Net Profit

10.80

-0.30

3,700.00%

Operating Profit Margin (Excl OI)

-180.70%

-3,690.60%

350.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 100.00% vs -88.89% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 3,700.00% vs -200.00% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

0.40

7.60

-94.74%

Operating Profit (PBDIT) excl Other Income

-2.20

-3.70

40.54%

Interest

0.10

1.30

-92.31%

Exceptional Items

0.30

1.40

-78.57%

Consolidate Net Profit

-4.60

-4.40

-4.55%

Operating Profit Margin (Excl OI)

-5,999.70%

-526.80%

-547.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -94.74% vs 18.75% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -4.55% vs -175.86% in Mar 2024

All Annual Results